Clinical trial
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 · Texas Heart Institute, Other · Completed
Key facts
| NCT number | NCT00203203 |
|---|---|
| Title | Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) |
| Official title | Randomized Controlled Single Blind Trial of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Therapeutic Angiogenesis |
| Lead sponsor | Texas Heart Institute, Other |
| Collaborators | CHI St. Luke's Health, Texas |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ischemic Cardiomyopathy |
| Intervention type | Device, Other |
| Interventions | Intramyocardial Injection of stem cells via NOGA Mapping, Control, then Stem Cell Therapy |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: